Oramed Pharmaceuticals
Manufacturing · New York, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
1185 Avenue of the Americas Fl 3, New Yo...Phone Number
(844) 967-2633Website
www.oramed.comRevenue
-Stock Symbol
ORMPIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1
About Oramed Pharmaceuticals
Oramed Pharmaceuticals, or Oramed (), is a publicly traded company engaged in the development of oral drug delivery systems most notably an oral insulin capsule for treating type 2 diabetes. The company was founded in 2006 and is headquartered in Jerusalem. Its shares are listed on the NASDAQ Capital Market and the Tel Aviv Stock Exchange.Explore more
Oramed Pharmaceuticals Org Chart
AG
Chief Financial Officer
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Oramed Pharmaceuticals your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Oramed Pharmaceuticals, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Product Launch: Get notified when Oramed Pharmaceuticals launches new products
Check out if Oramed Pharmaceuticals is spiking on competitors!
Click to see if Oramed Pharmaceuticals had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at Oramed Pharmaceuticals
Check if Oramed Pharmaceuticals has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on Oramed Pharmaceuticals recently announced quarterly report
Funding: Get notified immidiatlly once Oramed Pharmaceuticals has new funding data
Recommended Actions
Find VP level buyers at Oramed Pharmaceuticals
Find more new buyers
Compare Similar Companies to Oramed Pharmaceuticals
Compare insights from companies similar to Oramed Pharmaceuticals, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Oramed Pharmaceuticals is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Oramed Pharmaceuticals is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Oramed Pharmaceuticals.
Oramed Pharmaceuticals financials insights
Gather financial insights about Oramed Pharmaceuticals, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2025
Stock/Share Issuance
$36.9M
Oramed Pharmaceuticals Tech Stack
A closer look at the technologies used by Oramed Pharmaceuticals
See more technologies
Most Recent Scoops
Funding
Funding
Left Company
Executive Move
Executive Moves, Left Company
New Hire
Executive Move
Executive Moves, New Hire, Board of Directors
New Hire
Executive Move
Executive Moves, New Hire, Board of Directors
Left Company
Executive Move
Executive Moves, Left Company
Oramed Pharmaceuticals News & Media
Oramed Pharmaceuticals to Join Russell 2000® and Russell 3000® Indexes
NEW YORK, June 17, 2026 /PRNewswire/ -- Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) (TASE: ORMP) (www.oramed.com), announced today that it is set to join the U.S. small cap Russell 2000® and broad-market Russell 3000® Index at the conclusion of the 2026 Russell indexes semi-annual...Lifeward Successfully Closes on Strategic Partnership with Oramed
HUDSON, Mass. and YOKNEAM ILLIT, Israel, March 25, 2026 (GLOBE NEWSWIRE) -- Lifeward Ltd. (Nasdaq: LFWD) (“Lifeward” or the “Company”), a global...Lifeward Receives Shareholder Approval to Close on Strategic Partnership with Oramed—Creating Diversified Biomedical Company
Positions Lifeward as a diversified biomedical innovation company with clear path to profitabilityOramed and Lifeward Announce Strategic Transaction - PR Newswire
Transaction Will Transfer Oramed's Oral Drug Delivery Platform (POD™ Technology) to Lifeward and Positions Oramed as a Significant Shareholder Oramed will...
Read more news
Top Manufacturing Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Oramed Pharmaceuticals
Sign Up For FreeTo access detailed company insights
Oramed Pharmaceuticals, or Oramed (), is a publicly traded company engaged in the development of oral drug delivery systems most notably an oral insulin capsule for treating type 2 diabetes. The company was founded in 2006 and is headquartered in Jerusalem. Its shares are listed on the NASDAQ Capital Market and the Tel Aviv Stock Exchange.... Read More
